Categories: News

SRx Health Solutions Allocates Further Capital to its Digital Asset Treasury Hedging Strategy, Bringing Total Allocation to $18 Million

NORTH PALM BEACH, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) today announced allocating further capital to its digital treasury management strategy with the purchase of Bitcoin, bringing its total allocation in cryptocurrency to $18 million across Bitcoin and Ethereum.

The investment has been executed according to internally developed models to preserve long-term optionality across volatile market regimes and was made as part of the Company’s broader capital allocation strategy, which seeks to deploy excess liquidity into publicly traded securities such as Opendoor, digital assets, and commodities such as gold and silver that management believes are undervalued and offer attractive risk-adjusted return potential for shareholders.

The Company may increase or decrease its ownership position from time to time, depending on market conditions, valuation, and other strategic considerations. This investment does not impact SRXH’s core operational focus.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com

Media Contact
KCSA Strategic Communications
Kristin Cwalinski, Senior Vice President
EMJX@KCSA.com

Staff

Recent Posts

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities

LONDON, UK / ACCESS Newswire / January 28, 2026 / THE INFORMATION CONTAINED WITHIN THIS…

1 hour ago

Invitation to Cosmo’s Full Year 2025 Financial Results Webcast on 9 March 2026

Dublin, Ireland--(Newsfile Corp. - January 28, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

2 hours ago

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the…

4 hours ago

REJUVA FRESH® Unveils Three Cutting-Edge Technologies to Empower Providers with a Competitive Edge in 2026

ELLSWORTH, Maine, Jan. 27, 2026 /PRNewswire/ -- At the start of 2026, forward-thinking providers are…

10 hours ago

Revance Executives to Present at IMCAS World Congress 2026

Jeff Bedard and Conor Gallagher to share insights on aesthetic and therapeutic innovationNASHVILLE, Tenn., Jan.…

10 hours ago